Suggestions
Tamara Elias, M.D.
Grow, Scale, and Lead Business Transformation and Innovation | Senior Healthcare Executive | Board member
Tamara Elias, M.D., is a prominent figure in the healthcare sector, currently serving as an advisor on the Advisory Council at BrightInsight, a leading platform for biopharma and medtech regulated digital health solutions. Her extensive career spans over 20 years, encompassing various roles in clinical practice, strategic consulting, and corporate leadership.
Professional Background
- Current Role: Dr. Elias is the Senior Vice President of Strategy and Business Incubation at Nuance Communications, a Microsoft company. In this position, she focuses on integrating advanced technologies to enhance healthcare workflows and improve diagnostic processes.12
- Previous Experience: Before joining Nuance, she held significant roles at major healthcare organizations:
- Merck: Vice President of Global Partnerships & Innovation.
- Aetna: Vice President of Clinical Product Development.
- Becton Dickinson: Vice President of Strategy and Business Development.
- Essex Woodlands Health Partners: Partner.
- McKinsey & Company: Strategy consultant focusing on the pharmaceutical and medical device sectors.
- General Surgeon: Early in her career, she practiced as a general surgeon.123
Education
Dr. Elias holds a Bachelor of Arts in both Biology and Anthropology from Yale University and earned her M.D. from The Johns Hopkins School of Medicine.4
Contributions to BrightInsight
As a member of the BrightInsight Advisory Council, Dr. Elias leverages her vast experience to guide the company in enhancing its digital health offerings. She emphasizes the importance of integrating digital solutions into biopharma to drive value and differentiation for therapies.12 Her insights are expected to significantly influence the advancement of digital health technologies within the life sciences industry.
Board Memberships
In addition to her advisory role at BrightInsight, Dr. Elias serves on the boards of several medical companies, including Avinger (NASDAQ: AVGR), REVA Medical LLC, and BehaVR.12
Dr. Elias's multifaceted expertise positions her as a key player in shaping the future of healthcare technology and innovation.
